Latest research on Dexmethylphenidate

Dexmethylphenidate is the dextrorotary form of methylphenidate. It is a norepinephrine-dopamine reuptake inhibitor (NDRI) and thus a psychostimulant. It is used for treatment of Attention Deficit Hyperactivity Disorder (ADHD).

Dexmethylphenidate side effects

Using Dexmethylphenidate does allow for a lower dose to be used and increases the duration of action by 1–2 hours. [source, 2010]
On the CGI-S scale, Dexmethylphenidate subjects also had greater decreases than placebo: 68.4%, 61.1%, 64.8%, and 41.5%. [source, 2010]
Dexmethylphenidate showed slightly lower rates of increased heart rate (4.4 bpm and 3.7 bpm). [source, 2010]
In studies of reinforcement or self-administration, 13/15 trials reported increased rates of abuse with MPH or Dexmethylphenidate over placebo. [source, 2010]
MPH and Dexmethylphenidate showed increased rates as well.22 [source, 2010]
Adler et al21 demonstrated dose-related increases in weight loss with Dexmethylphenidate. [source, 2010]